Scientists have found another form of treatment for the ‘silent killer’ diabetes which they believe is more effective in comparison to the conventional treatments.
A new study has showed that an external artificial pancreas can help in improving the glucose levels and treating Type-1 diabetes.
Type-1 diabetes is a chronic disease that leads to vision loss and various cardiovascular diseases. This form of diabetes is caused from the destruction of autoimmune system of the insulin-producing beta cells present in the pancreas. This further leads to surge in blood and urine glucose.
According to the researchers, it is an emerging technology for the Type-1 diabetes treatment. The external artificial pancreas is an automated system that initiates the simulation of the normal pancreas by the continuous adaption of insulin delivery based on the changes in levels of glucose.
Scientists said there are two configurations behind the new treatment – Firstly, the single-hormone artificial pancreas delivering insulin alone and secondly, the dual-hormone artificial pancreas delivering both glucagon and insulin.
Insulin helps in lowering the blood glucose levels, while the glucagon raises glucose levels.
Explaining the findings of the study, investigator Ahmad Haidar, of Institut De Recherche Clinique De Montreal (IRCM), said, “Our study confirms that both artificial pancreas systems improve glucose control and reduce the risk of hypoglycemia compared to conventional pump therapy.”
The study was published in the journal The Lancet Diabetes & Endocrinology.